Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)

OBJECTIVE: To evaluate the effect of tocilizumab (TCZ), an interleukin 6 receptor inhibitor, on humoral immune responses to immunisations in patients with rheumatoid arthritis (RA). METHODS: Patients with RA with inadequate response/intolerance to one or more anti-tumour necrosis factor-α agents wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Bingham, Clifton O, Rizzo, Warren, Kivitz, Alan, Hassanali, Azra, Upmanyu, Ruchi, Klearman, Micki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392200/
https://www.ncbi.nlm.nih.gov/pubmed/24448345
http://dx.doi.org/10.1136/annrheumdis-2013-204427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392200/
https://www.ncbi.nlm.nih.gov/pubmed/24448345
http://dx.doi.org/10.1136/annrheumdis-2013-204427

Ejemplares similares